Answers are grounded in this paper and cite their sources.
Mefenamic acid (MFA; Ponstel®, USA) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat inflammatory pain. Despite its effectiveness, it carries an FDA black box warning for serious adverse effects, including hepatotoxicity, agranulocytosis, and gastrointestinal injury. While these toxicities are often linked to oxidative stress, the molecular mechanisms remain poorly understood. A key interaction occurs between MFA and myeloperoxidase (MPO), a heme enzyme released from activated neutrophils during inflammation. MPO catalyzes MFA’s one-electron oxidation, forming reactive metabolites that modify cellular macromolecules and potentially induce oxidative stress and immune-mediated cytotoxicity. This study examined whether MPO-mediated metabolism of MFA contributes to oxidative damage and cell death in HL-60 promyelocytic leukemia cells. Using compartment-specific spin probes and EPR spectroscopy, MFA was found to increase oxidant production in both cytosolic and mitochondrial compartments. MFA also caused an 80% loss of mitochondrial membrane potential, activated the Nrf2 antioxidant response, and suppressed phospho-ERK1/2 signaling—changes significantly reversed by PF-1355, a selective MPO inhibitor. Immuno-spin trapping revealed a 133-fold increase in protein-centered radicals following MFA exposure, which was reduced by 97% with MPO inhibition. Proteomic analysis identified MPO and HSPD1 among the most significantly modified proteins. These findings provide mechanistic insight that MPO-mediated oxidation of MFA generates reactive protein-free radicals, which disrupt redox signaling and protein integrity—ultimately contributing to mitochondrial dysfunction, oxidative stress, and cytotoxicity under inflammatory conditions. This mechanism provides insight into NSAID-induced oxidative injury and supports targeting MPO to improve drug safety under inflammatory conditions. • MFA forms protein radicals via MPO-catalyzed bioactivation in HL-60 cells • PF-1355 attenuates MFA-induced oxidative stress and cytotoxicity • Mitochondrial dysfunction and redox signaling disruption observed with MFA • Proteomic profiling reveals Hsp60, MPO, and TRiC complex as radical targets • MPO-mediated protein adduction may underlie MFA-induced immune toxicity
No takes yet. Share an insight, caveat, or question.
Tran et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: